We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUD
676
DELISTED
Audacy, Inc.
AUD
| $1.25M | 0.01% |
103,321
+24,298
| +31% | +$290K |
|
|
RAI
677
DELISTED
Reynolds American Inc
RAI
| $1.25M | 0.01% |
+36,378
| New | +$1.27M |
|
678
Lazard
LAZ
$4.19B
| $1.25M | 0.01% |
23,692
| – | – |
|
|
ZNH
679
DELISTED
China Southern Airlines Company Limited
ZNH
| $1.24M | 0.01% |
34,416
+14,969
| +77% | +$392K |
|
|
TVTY
680
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.23M | 0.01% |
62,429
-32,970
| -35% | -$689K |
|
|
ACH
681
DELISTED
Alum Corp of China Ltd
ACH
| $1.22M | 0.01% |
97,766
+78,090
| +397% | +$928K |
|
|
PZE
682
DELISTED
Petrobras Argentina S A
PZE
| $1.21M | 0.01% |
177,285
-286,722
| -62% | -$1.6M |
|
|
CDI
683
DELISTED
CDI Corp.
CDI
| $1.21M | 0.01% |
86,102
+18,295
| +27% | +$299K |
|
|
CSC
684
DELISTED
Computer Sciences
CSC
| $1.2M | 0.01% |
43,673
-138,680
| -76% | -$3.83M |
|
|
RLD
685
DELISTED
REALD INC COM STK
RLD
| $1.19M | 0.01% |
92,951
+49,558
| +114% | +$594K |
|
|
ISLE
686
DELISTED
Isle of Capri Casinos Inc
ISLE
| $1.18M | 0.01% |
84,225
-31,952
| -28% | -$367K |
|
|
AAT
687
American Assets Trust
AAT
$1.37B
| $1.18M | 0.01% |
27,172
-29,554
| -52% | -$1.26M |
|
|
MNI
688
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $1.18M | 0.01% |
63,903
| – | – |
|
|
SRDX
689
DELISTED
Surmodics
SRDX
| $1.17M | 0.01% |
44,839
-4,000
| -8% | -$95.3K |
|
690
Fidelity National Financial
FNF
$13.2B
| $1.16M | 0.01% |
+45,469
| New | +$1.15M |
|
691
Everest Group
EG
$14.3B
| $1.14M | 0.01% |
6,559
+4,778
| +268% | +$839K |
|
692
Church & Dwight Co
CHD
$24.3B
| $1.13M | 0.01% |
+26,512
| New | +$1.1M |
|
693
Royal Bank of Canada
RY
$294B
| $1.13M | 0.01% |
18,775
-179,271
| -91% | -$11M |
|
|
VISN
694
Vistance Networks Inc
VISN
$2.52B
| $1.12M | 0.01% |
+39,400
| New | +$1.1M |
|
695
Federal Signal
FSS
$7.77B
| $1.12M | 0.01% |
70,919
+24,458
| +53% | +$381K |
|
696
PENN Entertainment
PENN
$2.64B
| $1.12M | 0.01% |
71,300
+16,727
| +31% | +$263K |
|
|
NTUS
697
DELISTED
Natus Medical Inc
NTUS
| $1.09M | 0.01% |
+27,574
| New | +$1.02M |
|
698
Sonic Automotive
SAH
$2.55B
| $1.09M | 0.01% |
43,604
+899
| +2% | +$22.7K |
|
699
ESCO Technologies
ESE
$7.91B
| $1.08M | 0.01% |
27,752
-37,005
| -57% | -$1.39M |
|
700
Tootsie Roll Industries
TR
$2.95B
| $1.08M | 0.01% |
44,153
-53,542
| -55% | -$1.23M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.